Fineline Cube

Follow:
14499 Articles
Kexing Biopharm's GB18 Receives FDA Approval for Tumor Cachexia Clinical Trial
CompanyDrug

Kexing Biopharm’s GB18 Receives FDA Approval for Tumor Cachexia Clinical Trial

Accropeutics' AC-201 Shows Positive Phase II Results in Psoriasis Treatment
CompanyDrug

Accropeutics’ AC-201 Shows Positive Phase II Results in Psoriasis Treatment

Simcere's FGFR2b-Targeting ADC SIM0686 Enters Phase I Clinical Study
CompanyDrug

Simcere’s FGFR2b-Targeting ADC SIM0686 Enters Phase I Clinical Study

Triastek's T22 Gastric Retention Capsules Gain NMPA IND Clearance
CompanyDrug

Triastek’s T22 Gastric Retention Capsules Gain NMPA IND Clearance

Boehringer Ingelheim's Metalyse Approved in China for Acute Ischemic Stroke
CompanyDrug

Boehringer Ingelheim’s Metalyse Approved in China for Acute Ischemic Stroke

Well Lead Medical to Set Up Subsidiary and Manufacturing Base in Indonesia
Company

Well Lead Medical to Set Up Subsidiary and Manufacturing Base in Indonesia

Kelun-Biotech's Sacituzumab Tirumotecan Accepted for NMPA Review for HR+, HER2- Breast Cancer
CompanyDrug

Kelun-Biotech’s Sacituzumab Tirumotecan Accepted for NMPA Review for HR+, HER2- Breast Cancer

Shandong Buchang Pharmaceuticals Partners with FBC for MF59 Adjuvant R&D
CompanyDeals

Shandong Buchang Pharmaceuticals Partners with FBC for MF59 Adjuvant R&D

HHS Implements Trump's Order for Most-Favored-Nation Drug Pricing
Policy / Regulatory

HHS Implements Trump’s Order for Most-Favored-Nation Drug Pricing

Nuance Pharma's Ohtuvayre Meets Primary Endpoints in COPD Study
CompanyDrug

Nuance Pharma’s Ohtuvayre Meets Primary Endpoints in COPD Study

AccurEdit Therapeutics' ART001 Receives FDA RMAT Designation for ATTR
CompanyDrug

AccurEdit Therapeutics’ ART001 Receives FDA RMAT Designation for ATTR

AstraZeneca Completes Acquisition of EsoBiotec for Up to USD 1 Billion
CompanyDeals

AstraZeneca Completes Acquisition of EsoBiotec for Up to USD 1 Billion